Valuation: Integer Holdings Corporation

Capitalization 2.96B 2.55B 2.31B 2.22B 4.05B 273B 4.19B 27.14B 10.86B 130B 11.11B 10.87B 465B P/E ratio 2026 *
21.6x
P/E ratio 2027 * 17x
Enterprise value 2.96B 2.55B 2.31B 2.22B 4.05B 273B 4.19B 27.14B 10.86B 130B 11.11B 10.87B 465B EV / Sales 2026 *
1.6x
EV / Sales 2027 * 1.5x
Free-Float
98.48%
Yield 2026 *
-
Yield 2027 * -
1 day-0.83%
1 week-0.54%
Current month-0.75%
1 month+0.60%
3 months+21.82%
6 months-19.30%
Current year+9.69%
1 week 83.31
Extreme 83.31
87.84
1 month 82.76
Extreme 82.76
100.05
Current year 76.21
Extreme 76.21
100.05
1 year 62
Extreme 62
127.56
3 years 62
Extreme 62
146.36
5 years 50.05
Extreme 50.05
146.36
10 years 18.1
Extreme 18.1
146.36
Manager TitleAgeSince
Chief Executive Officer 56 24/10/2025
Director of Finance/CFO 53 08/05/2023
Investor Relations Contact - -
Director TitleAgeSince
Chairman 77 01/07/2002
Director/Board Member 65 02/07/2015
Director/Board Member 67 02/07/2015
Change 5d. change 1-year change 3-years change Capi.($)
-0.83%-0.54%-27.24%+11.73% 2.96B
+0.90%-0.19%-0.75%-8.36% 190B
+0.76%-0.99%-10.18%+113.39% 178B
+0.35%-2.29%-0.57%-19.12% 145B
-2.22%-1.73%-30.31%+51.00% 107B
-2.28%-4.51%-23.59%-20.06% 53.73B
-0.07%+2.18%+19.39%+4.03% 49.5B
+0.30%+2.58%+11.91%+17.85% 37.74B
+1.14%-5.96%-6.27%+3.47% 36.01B
+1.26%-3.35%-2.05%-16.25% 34.06B
Average -0.38%-1.08%-6.97%+13.77% 83.44B
Weighted average by Cap. -0.31%-1.07%-6.62%+24.79%

Financials

2026 *2027 *
Net sales 1.85B 1.59B 1.44B 1.38B 2.53B 170B 2.62B 16.94B 6.78B 81.25B 6.94B 6.79B 290B 1.97B 1.69B 1.54B 1.47B 2.69B 181B 2.79B 18.05B 7.23B 86.54B 7.39B 7.23B 309B
Net income 138M 119M 108M 103M 188M 12.71B 195M 1.26B 506M 6.06B 518M 506M 21.65B 175M 151M 137M 131M 239M 16.14B 248M 1.61B 643M 7.7B 657M 643M 27.49B
Net Debt - -
Logo Integer Holdings Corporation
Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. It operates through Medical segment, which includes the cardio and vascular; cardiac rhythm management and neuromodulation, and advanced surgical; orthopedics and portable medical product lines. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease.
Employees
11,000
Date Price Change Volume
04/03/26 86.03 $ -0.83% 793,376
03/03/26 86.75 $ +0.47% 707,341
02/03/26 86.34 $ -0.39% 771,094
27/02/26 86.68 $ -0.10% 1,163,302
26/02/26 86.77 $ +0.31% 761,483
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
86.03USD
Average target price
92.62USD
Spread / Average Target
+7.67%

Quarterly revenue - Rate of surprise